Dianthus Therapeutics, Inc.

DNTHNASDAQHealthcareBiotechnology

$72.09- (-)1Y +108.67%

As of Oct 16, 2026 close

Market cap: $4.17B
P/E (TTM): -
Forward P/E: -
Dividend yield: -
52-week range: $32.22$117.88
Volume (live): -
Avg. volume (3M): 927.58K

Dianthus Therapeutics, Inc. (DNTH) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Dianthus Therapeutics, Inc. stock.

Analyst Consensus Rating

Investment consensus from 13 professional research analysts

Consensus Rating

Buy

Based on 13 unique analysts

(14 total ratings in last 90 days)

High Confidence∞:1 Buy/Sell

Average Price Target

$142.82

+98.11% upside

Loading chart...

Strong Sell

Sell

Hold

Buy

Strong Buy

Latest DNTH Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Date	Analyst	Firm	Action	Rating	Price Target
Oct 15, 2026	Swayampakula Ramakanth	HC Wainwright	Reiterates	Buy	$158.00
Oct 1, 2026	Swayampakula Ramakanth	HC Wainwright	Reiterates	Buy	$158.00
Sep 29, 2026	Rami Katkhuda	LifeSci Capital	Maintains	Buy	$125.00
Sep 24, 2026	Brian Cheng	JP Morgan	Reiterates	Buy	-
Sep 18, 2026	Myles Minter	William Blair	Reiterates	Buy	-
Sep 4, 2026	Samantha Semenkow	Citi	Initiates	Buy	$156.00
Aug 13, 2026	Alex Thompson CFA	Stifel Nicolaus	Maintains	Buy	$133.00
Aug 10, 2026	Gavin Clark-Gartner	Evercore ISI Group	Maintains	Buy	$134.00
Aug 6, 2026	Danielle Brill	Truist	Maintains	Buy	$110.00 → $128.00 +18.00 (+16.4%)
Aug 5, 2026	William Maughan	Clear Street	Maintains	Buy	$130.00
Aug 5, 2026	Laura Chico	Wedbush	Maintains	Buy	$105.00 → $122.00 +17.00 (+16.2%)
Aug 5, 2026	Yatin Suneja	Guggenheim	Reiterates	Buy	$200.00
Aug 5, 2026	Yaron Werber	TD Cowen	Initiates Coverage	Buy	$150.00
Aug 5, 2026	Sadia Rahman	Wells Fargo	Maintains	Buy	$135.00

Swayampakula Ramakanth

HC Wainwright

BuyReiterates

$158.00

Oct 15

Swayampakula Ramakanth

HC Wainwright

BuyReiterates

$158.00

Oct 1

Rami Katkhuda

LifeSci Capital

BuyMaintains

$125.00

Sep 29

Brian Cheng

JP Morgan

BuyReiterates

Sep 24

Myles Minter

William Blair

BuyReiterates

Sep 18

Samantha Semenkow

Citi

BuyInitiates

$156.00

Sep 4

Alex Thompson CFA

Stifel Nicolaus

BuyMaintains

$133.00

Aug 13

Gavin Clark-Gartner

Evercore ISI Group

BuyMaintains

$134.00

Aug 10

Danielle Brill

Truist

BuyMaintains

$110.00 → $128.00

Aug 6

William Maughan

Clear Street

BuyMaintains

$130.00

Aug 5

Laura Chico

Wedbush

BuyMaintains

$105.00 → $122.00

Aug 5

Yatin Suneja

Guggenheim

BuyReiterates

$200.00

Aug 5

Yaron Werber

TD Cowen

BuyInitiates Coverage

$150.00

Aug 5

Sadia Rahman

Wells Fargo

BuyMaintains

$135.00

Aug 5

Source: Professional analyst ratings and price targets from the last 90 days. Data as of Oct 15, 2026. Data sources and methodology

Frequently Asked Questions

What is the analyst consensus rating for DNTH?

The analyst consensus rating for DNTH is Buy, based on the latest ratings from 13 analysts over the last 90 days.

What is the average price target for DNTH?

The average 12-month price target for DNTH is $142.82, representing an upside of 98.1% from the Oct 16, 2026 close of $72.09.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.